Megan Lynn Schultz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Megan Lynn Schultz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Brian Lim
Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
2 shared publications - Ming-Sing Si
Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
2 shared publications Aaron M. Williams
Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication- Alexander Jaworski
Department of Neuroscience, Brown University
1 shared publication Andre Monteiro Da Rocha
Division of Cardiovascular Medicine, Department of Internal Medicine (A.M.D.R., T.H.), Michigan Medicine, Ann Arbor
1 shared publication- Anne Eichmann
Department of Cellular and Molecular Physiology, Yale University School of Medicine
1 shared publication
Latest Publications
- 25 July 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (9) , 103623
Time to Teach: Threading the Education Needle in the High-Stakes Cardiac Surgery Operating Room
- 25 July 2025
- Published by Elsevier in Journal of Surgical Education
- Vol. 82 (9) , 103623
Time to Teach: Threading the Education Needle in the High-Stakes Cardiac Surgery Operating Room
- Open Access
- 29 March 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 134 (7) , 913-930
Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy
BACKGROUND: Recently shown to regulate cardiac development, the secreted axon guidance molecule SLIT3 maintains its expression in the postnatal heart. Despite its known expression in the cardiovascular system after birth, SLIT3’s relevance to cardiovascular function in the postnatal state remains unknown. As such, the objectives of this study were to determine the postnatal myocardial sources of SLIT3 and to evaluate its functional role in regulating the cardiac response to pressure overload stress. METHODS: We performed in vitro studies on cardiomyocytes and myocardial tissue samples from patients and performed in vivo investigation with SLIT3 and ROBO1 (roundabout homolog 1) mutant mice undergoing transverse aortic constriction to establish the role of SLIT3-ROBO1 in adverse cardiac remodeling. RESULTS: We first found that SLIT3 transcription was increased in myocardial tissue obtained from patients with congenital heart defects that caused ventricular pressure overload. Immunostaining of hearts from WT (wild-type) and reporter mice revealed that SLIT3 is secreted by cardiac stromal cells, namely fibroblasts and vascular mural cells, within the heart. Conditioned media from cardiac fibroblasts and vascular mural cells both stimulated cardiomyocyte hypertrophy in vitro, an effect that was partially inhibited by an anti-SLIT3 antibody. Also, the N-terminal, but not the C-terminal, fragment of SLIT3 and the forced overexpression of SLIT3 stimulated cardiomyocyte hypertrophy and the transcription of hypertrophy-related genes. We next determined that ROBO1 was the most highly expressed roundabout receptor in cardiomyocytes and that ROBO1 mediated SLIT3’s hypertrophic effects in vitro. In vivo, Tcf21+ fibroblast and Tbx18+ vascular mural cell-specific knockout of SLIT3 in mice resulted in decreased left ventricular hypertrophy and cardiac fibrosis after transverse aortic constriction. Furthermore, α-MHC+ cardiomyocyte-specific deletion of ROBO1 also preserved left ventricular function and abrogated hypertrophy, but not fibrosis, after transverse aortic constriction. CONCLUSIONS: Collectively, these results indicate a novel role for the SLIT3-ROBO1–signaling axis in regulating postnatal cardiomyocyte hypertrophy induced by pressure overload.
- 29 March 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 134 (7) , 913-930
Open AccessStromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy
BACKGROUND: Recently shown to regulate cardiac development, the secreted axon guidance molecule SLIT3 maintains its expression in the postnatal heart. Despite its known expression in the cardiovascular system after birth, SLIT3’s relevance to cardiovascular function in the postnatal state remains unknown. As such, the objectives of this study were to determine the postnatal myocardial sources of SLIT3 and to evaluate its functional role in regulating the cardiac response to pressure overload stress. METHODS: We performed in vitro studies on cardiomyocytes and myocardial tissue samples from patients and performed in vivo investigation with SLIT3 and ROBO1 (roundabout homolog 1) mutant mice undergoing transverse aortic constriction to establish the role of SLIT3-ROBO1 in adverse cardiac remodeling. RESULTS: We first found that SLIT3 transcription was increased in myocardial tissue obtained from patients with congenital heart defects that caused ventricular pressure overload. Immunostaining of hearts from WT (wild-type) and reporter mice revealed that SLIT3 is secreted by cardiac stromal cells, namely fibroblasts and vascular mural cells, within the heart. Conditioned media from cardiac fibroblasts and vascular mural cells both stimulated cardiomyocyte hypertrophy in vitro, an effect that was partially inhibited by an anti-SLIT3 antibody. Also, the N-terminal, but not the C-terminal, fragment of SLIT3 and the forced overexpression of SLIT3 stimulated cardiomyocyte hypertrophy and the transcription of hypertrophy-related genes. We next determined that ROBO1 was the most highly expressed roundabout receptor in cardiomyocytes and that ROBO1 mediated SLIT3’s hypertrophic effects in vitro. In vivo, Tcf21+ fibroblast and Tbx18+ vascular mural cell-specific knockout of SLIT3 in mice resulted in decreased left ventricular hypertrophy and cardiac fibrosis after transverse aortic constriction. Furthermore, α-MHC+ cardiomyocyte-specific deletion of ROBO1 also preserved left ventricular function and abrogated hypertrophy, but not fibrosis, after transverse aortic constriction. CONCLUSIONS: Collectively, these results indicate a novel role for the SLIT3-ROBO1–signaling axis in regulating postnatal cardiomyocyte hypertrophy induced by pressure overload.
- Open Access
- 25 March 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 441-443
Bicuspidization of Insufficient Neoaortic Valve After Arterial Switch With Looping Coronary Anatomy
- 25 March 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 1 (3) , 441-443
Open AccessBicuspidization of Insufficient Neoaortic Valve After Arterial Switch With Looping Coronary Anatomy
- 6 March 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 170, 147-154
Relation of Community-Level Socioeconomic Status to Delayed Diagnosis of Acute Type A Aortic Dissection
- 6 March 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 170, 147-154
Relation of Community-Level Socioeconomic Status to Delayed Diagnosis of Acute Type A Aortic Dissection
- Open Access
- 17 August 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11) , 1374-1376
Aortic recoarctation and pseudoaneurysm five decades after repair
Background: Coarctation of the aorta is a congenital cardiac defect characterized by a narrowing of the proximal thoracic aorta. Despite excellent long‐term results, surgical repair is rarely complicated by recoarctation. Methods/Results: We describe a case with the longest time to reintervention to date, featuring surgical repair of delayed aortic recoarctation and pseudoaneurysm 53 years after the initial operation. Discussion: This case emphasizes the need for lifelong surveillance in this patient population and exemplifies a multidisciplinary approach in evaluating treatment options of complex aortic pathology, including open and endovascular considerations.
- 17 August 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11) , 1374-1376
Open AccessAortic recoarctation and pseudoaneurysm five decades after repair
Background: Coarctation of the aorta is a congenital cardiac defect characterized by a narrowing of the proximal thoracic aorta. Despite excellent long‐term results, surgical repair is rarely complicated by recoarctation. Methods/Results: We describe a case with the longest time to reintervention to date, featuring surgical repair of delayed aortic recoarctation and pseudoaneurysm 53 years after the initial operation. Discussion: This case emphasizes the need for lifelong surveillance in this patient population and exemplifies a multidisciplinary approach in evaluating treatment options of complex aortic pathology, including open and endovascular considerations.